Acıbadem Maslak Hospital

Acıbadem Maslak Hospital is the flagship facility of the Acıbadem Healthcare Group, Turkey's largest private healthcare network founded in 1991 by Dr. Mehmet Ali Aydınlar. The group operates 29 hospitals and 15 medical centers across 5 countries (Turkey, Bulgaria, Macedonia, Serbia, Netherlands), serving over 5 million patients annually with 29,000 employees. The Maslak campus features 364 beds, 20 operating rooms, 27 ICU beds, and 75 chemotherapy rooms. It holds LEED Gold certification as an environmentally sustainable facility. The hospital's Oncology program spans 7 dedicated cancer centers offering CyberKnife, TrueBeam STx, RapidArc radiotherapy, immunotherapy, and chemotherapy. The Robotic Surgery Center utilizes the Da Vinci system for minimally invasive procedures across urology, colorectal, and gynecologic surgery. The Neurosurgery Department features Gamma Knife radiosurgery and 3-Tesla intraoperative MRI in collaboration with Siemens. The Orthopedics Department offers Navio robotic knee replacement technology. Acıbadem has maintained academic partnerships with Harvard Medical International since 2003 and Massachusetts General Hospital. The group is 90% owned by IHH Healthcare Berhad (Malaysia), the world's second-largest healthcare chain. The Sports Medicine Center holds FIFA Medical Centre of Excellence status (1 of 33 globally). Additional capabilities include organ transplantation (kidney, liver), bone marrow transplant (adult and pediatric), 10 IVF units, and comprehensive diagnostic imaging with PET-CT and 4D breast ultrasound. The Ataşehir campus features an AI-powered Digital Command Center for real-time patient monitoring.